Sellman et al v. Boehringer Ingelheim Pharmaceuticals Inc et al
| Gregory Sellman and Vincent Navarre |
| Boehringer Ingelheim Pharmaceuticals, Inc., Robert Kime and Boehringer Ingelheim Pharmaceuticals Inc |
| 2:2021cv01105 |
| August 17, 2021 |
| US District Court for the Western District of Washington |
| John C Coughenour |
| Civil Rights: Americans with Disabilities - Employment |
| 28 U.S.C. § 1441 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 27, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 31
SURREPLY filed by Plaintiffs Vincent Navarre, Gregory Sellman re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Cummings, John)
|
|
Filing 30
NOTICE of Intent to File Surreply ; filed by Plaintiffs Vincent Navarre, Gregory Sellman. (Cummings, John)
|
|
Filing 29
DECLARATION of Melissa Faughnan filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Attachments: #1 Exhibits H-M)(Johnsrud, Barry)
|
|
Filing 28
DECLARATION of Barry Alan Johnsrud filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Attachments: #1 Exhibits Q-S)(Johnsrud, Barry)
|
|
Filing 27
REPLY, filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime, TO RESPONSE to #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Johnsrud, Barry)
|
|
Filing 26
DECLARATION Signed Supplemental Declaration of Greg Sellman re #23 SUPPLEMENTAL DECLARATION by Plaintiff Gregory Sellman (Cummings, John) Modified on 10/12/2021 to correct document linkage (SR).
|
|
Filing 25
SUPPLEMENTAL DECLARATION of Vince Navarre by Plaintiff Vincent Navarre (Cummings, John) Modified on 10/12/2021 to edit document title (SR).
|
|
Filing 24
SUPPLEMENTAL DECLARATION of John M. Cummings by Plaintiffs Vincent Navarre, Gregory Sellman (Cummings, John) Modified on 10/12/2021 to edit document title (SR).
|
|
Filing 23
SUPPLEMENTAL DECLARATION of Greg Sellman by Plaintiff Gregory Sellman (Cummings, John) Modified on 10/12/2021 to edit document title (SR).
|
|
Filing 22
DECLARATION of John Cummings filed by Plaintiffs Vincent Navarre, Gregory Sellman re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Cummings, John)
|
|
Filing 21
DECLARATION of Greg Sellman filed by Plaintiff Gregory Sellman re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Cummings, John)
|
|
Filing 20
DECLARATION of Vincent Navarre filed by Plaintiff Vincent Navarre re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Cummings, John)
|
|
Filing 19
RESPONSE, by Plaintiffs Vincent Navarre, Gregory Sellman, to #16 MOTION to Compel Arbitration and Dismiss Lawsuit. (Attachments: #1 Proposed Order)(Cummings, John)
|
|
Filing 18
DECLARATION of Barry Alan Johnsrud filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Attachments: #1 Exhibit G)(Johnsrud, Barry)
|
|
Filing 17
DECLARATION of Tamille Barrett filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime re #16 MOTION to Compel Arbitration and Dismiss Lawsuit (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Johnsrud, Barry)
|
|
Filing 16
MOTION to Compel Arbitration and Dismiss Lawsuit, filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime. (Attachments: #1 Proposed Order) Noting Date 10/8/2021, (Johnsrud, Barry)
|
|
Filing 15
MINUTE ORDER granting Parties' #14 Stipulated Motion to Extend Defendants' Responsive Pleading Deadline. The deadline for Defendants to answer or otherwise respond to the complaint is September 16, 2021. Authorized by U.S. District Judge John C. Coughenour. (SR) Modified on 9/2/2021 to correct the date the order was entered, per the direction of chambers. Date has been changed and document has been replaced. NEF regenerated. (SR). (Main Document 15 replaced on 9/2/2021) (SR).
|
|
Filing 14
Joint Stipulated MOTION to Extend Defendants' Responsive Pleading Deadline, filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime. Noting Date 9/1/2021, (Minear, Jonathan)
|
|
Filing 13
MINUTE ENTRY SETTING INITIAL CASE MANAGEMENT DATES All counsel and any pro se parties are directed to meet and confer and to provide the Court with a combined Joint Status Report (the Report) by the deadline set below. This meet-and-confer must be a face-to-face meeting or a telephonic conference. If the parties are unable to agree on any part of the Report, they may answer in separate paragraphs; no separate reports are to be filed. The Report must contain the following information: 1. An estimate of the number of days needed for trial; 2. The date by which the case will be ready for trial; and 3. Whether the parties intend to mediate per LCR 39.1 and, if so, when the parties expect to complete mediation.The deadlines below may be extended only by court order. Any request for extension of these deadlines should be made by email to Courtroom Deputy Clerk Gabriel Traber at gabriel_traber@wawd.uscourts.gov. The parties who have appeared in this matter must meet and confer before contacting the Court to request an extension. If this case involves claims that are exempt from the requirements of FRCP 26(a) and 26(f), please notify the Courtroom Deputy Clerk. Please note: Initial Disclosures are not to be filed. FRCP 26(f) Conference Deadline is 1/10/2022, Initial Disclosure Deadline is 1/18/2022, Joint Status Report due by 1/24/2022. (GT)
|
|
Filing 12
In light of the current General Order restricting courtroom capacity to 25 people due to the highly contagious delta variant of the COVID-19 virus, the Status Conference in this matter is hereby stricken. The parties will be directed by separate entry to meet and confer and submit a joint status report.(GT)
|
|
Filing 11
VERIFICATION OF STATE COURT RECORDS by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime (Minear, Jonathan)
|
|
Filing 10
MINUTE ORDER granting Parties' #9 Stipulated Motion to Extend Defendants' Responsive Pleading Deadline. Defendants' response to the complaint is due September 2, 2021. If the parties determine this lawsuit is indeed subject to arbitration agreements, they must promptly advise the Court or file an appropriate dismissal notice. Authorized by U.S. District Judge John C. Coughenour. (SR)
|
|
Filing 9
Joint Stipulated MOTION to Extend Defendants' Responsive Pleading Deadline, filed by Defendants Boehringer Ingelheim Pharmaceuticals Inc, Robert Kime. Noting Date 8/19/2021, (Minear, Jonathan)
|
|
Filing 8
MINUTE ENTRY re: STATUS CONFERENCE. The attorney who will be responsible for trying the case, or that attorney's representative, should attend the conference and be prepared to discuss the following matters at the conference: 1. An estimate of the number of days needed for trial; 2. The date by which the case will be ready for trial; 3. Whether the parties intend to mediate per LCR 39.1 and, if so, when the parties expect to complete mediation; If counsel's office is outside of the Greater Metropolitan Seattle area, local counsel should attend on behalf of non-local counsel. If local counsel is unavailable, non-local counsel may make arrangements to participate telephonically in the conference by contacting the Courtroom Deputy Clerk at Gabriel_Traber@wawd.uscourts.gov at least TEN (10) DAYS in advance of the proceeding. Counsel do NOT need to file a Joint Status Report or Rule 26(f) Report in advance of the Status Conference. Counsel should plan on arriving 10-15 minutes early to check in with the Courtroom Deputy Clerk as the Court's calendar begins promptly at 9:00 a.m. COUNSEL OR THE PRO SE PARTY WHO FILED THIS MATTER SHALL IMMEDIATELY NOTIFY ALL PARTIES OF THE DATE AND TIME OF THE SCHEDULED STATUS CONFERENCE. Status Conference set for 12/7/2021 at 09:00 AM in Courtroom 16206 before U.S. District Judge John C. Coughenour. (GT)
|
|
Filing 7
ORDER REGARDING DISCOVERY AND DEPOSITIONS by U.S. District Judge John C. Coughenour. (GT)
|
|
Filing 6
LETTER from Clerk re receipt of case from King County Superior Court and advising of WAWD case number and judge assignment. (RE)
|
|
Filing 5
Notice of Filing Deficiency ***Action Required*** Notice of Removal - Jury Demand Improperly Submitted.See attached letter for more information and instructions. (RE)
|
|
U.S. District Judge John C. Coughenour added. (RE)
|
|
Filing 4
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Boehringer Ingelheim Pharmaceuticals, Inc., Robert Kime (Johnsrud, Barry)
|
|
Filing 3
DECLARATION of Tamille Barrett re #1 Notice of Removal by Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Robert Kime (Johnsrud, Barry)
|
|
Filing 2
DECLARATION of Barry Alan Johnsrud re #1 Notice of Removal by Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Robert Kime (Johnsrud, Barry)
|
|
Filing 1
NOTICE OF REMOVAL from King County Superior Court, case number served, not filed; (Receipt # BWAWDC-7212626), filed by Robert Kime, Boehringer Ingelheim Pharmaceuticals, Inc.. (Attachments: #1 Complaint, #2 Civil Cover Sheet)(Johnsrud, Barry)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Washington Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
